Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...
Donepezil was associated with improved verbal memory and processing speed compared to placebo in patients with TBI and severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results